Legal
WeWomen beta terms and conditions
Last updated: 9 November 2026
This English version is a translation provided for convenience. In case of discrepancy, the Spanish version prevails.
1. Provider
WeWomen is a service provided by BAUBER.XYZ, S.L., tax ID (NIF) B93944700, with registered office at Rambla del Poblenou, 38, 08005 Barcelona, Spain (hereinafter, «WeWomen»), which owns the Beta Version and is the data controller. Registry details: Section 8, Sheet B-662478, Entry 1 (registration date: 19/08/2026). Contact email: hola@wewomen.health.
WeWomen's business is expected to be transferred to a newly incorporated company, which will become the owner of the service and the data controller. WeWomen will notify the Participant by email, at least thirty days in advance, of the identity of the new data controller, the purposes of the processing and her rights under Articles 13 and 14 of the GDPR. The new company will assume all the obligations under these terms, including the free access provided for in clause 9, and will ask the Participant to accept these terms again, so that she can review them, and to give her explicit consent to the continued processing of her health data. If the Participant does not accept them, her data will be deleted within the period set out in clause 13. In the meantime, BAUBER.XYZ, S.L. processes the data solely to provide the WeWomen service.
2. Purpose and acceptance
These terms govern participation, by invitation and free of charge, in the beta version of WeWomen (hereinafter, the «Beta Version»). The invited person (hereinafter, the «Participant») accepts them by activating her access. If she does not agree with them, she must not use the Beta Version.
3. Eligibility
To take part, the Participant must be over 18 years of age and have received an invitation from WeWomen. Access is through a web application, using the email address to which the invitation was sent. The account is personal and non-transferable, and the Participant is responsible for keeping her credentials safe and for informing WeWomen of any unauthorised use.
4. Test nature
The Beta Version is under development and is provided as is and as available. It may contain errors, suffer interruptions and change without prior notice. WeWomen may add, modify or remove features while the Beta Version is available.
WeWomen applies appropriate technical and organisational measures to protect the information stored in the Beta Version, such as encryption in transit and access control. Even so, the Participant is advised to keep her own copies of the documents she uploads.
5. Nature of the service
WeWomen provides evidence-based health information for informational and educational purposes. It is not a medical device and does not provide medical services. It does not diagnose, treat or prescribe, and it does not replace consultation with healthcare professionals. The Participant must not start, stop or change any treatment on the basis of information from WeWomen without first consulting a healthcare professional, nor disregard or delay a healthcare professional's advice because of information obtained in WeWomen. Using WeWomen does not create a healthcare professional and patient relationship.
Information about the menstrual cycle, ovulation or fertility is not a method of contraception and does not guarantee achieving or avoiding a pregnancy. During pregnancy, breastfeeding or the treatment of an illness, particular caution is advised, and the Participant should always consult a healthcare professional.
WeWomen is not designed for emergencies and does not monitor the Participant's health. In a medical emergency, or if there is a risk to her safety or that of others, the Participant must immediately contact the emergency services of her country or go to the nearest healthcare centre. If using WeWomen causes her distress or worry, the Participant should stop using it and seek support from a professional.
6. Use of artificial intelligence
WeWomen's chat answers are generated by artificial intelligence systems. Answers generated by artificial intelligence are produced automatically and are not individually reviewed by healthcare professionals. They may be inaccurate or incomplete, so the Participant should not rely on them without checking them and, where they concern her health, without discussing them with a healthcare professional. Each answer shows its sources to make that check easier.
7. Participant's obligations
The Participant undertakes to use the Beta Version personally and lawfully and, in particular, not to upload health information about other people without their consent, to inform the healthcare professional and obtain her consent before transcribing a consultation, not to access other people's accounts, not to copy, decompile or extract by automated means the content or code of the platform, and not to circumvent its security measures. The Participant declares, under her own responsibility, that she has informed the people concerned and obtained the necessary consents before activating transcription.
WeWomen invites the Participant to use the Beta Version during the trial period, to report any errors and suggestions she identifies, and to answer the initial and final questionnaires.
8. Feedback and suggestions
Any comments, ratings and suggestions the Participant provides about the Beta Version are voluntary. WeWomen may use them freely to improve the service, with no obligation to provide compensation.
9. Thank-you for taking part
WeWomen thanks the Participant for the time she devotes to the Beta Version and the feedback she provides to improve it. As a thank-you, a Participant who provides feedback on the Beta Version may continue to use the commercial version of WeWomen free of charge until November 2027.
A Participant who does not provide feedback may use the Beta Version free of charge until 19 February 2027. After that date she will not have free access to the commercial version, although she may take out a paid subscription.
Free access until November 2027 is personal, cannot be transferred or exchanged for money, and does not renew automatically. When it ends, the Participant may decide whether to take out a paid subscription.
10. Free of charge
Participation in the Beta Version is free of charge. WeWomen will not ask the Participant for any payment or payment details while she uses the Beta Version.
11. Participant's content
The information the Participant uploads, writes or transcribes in WeWomen, and the answers she obtains from it, belong to her at all times, to the extent permitted by applicable law and without prejudice to the pre-existing rights of third parties. WeWomen only stores and processes it to provide her with the service while she keeps her account, under the terms of clause 13. WeWomen does not sell or transfer this content to third parties, except in the transfer described in clause 1. Nor does it use it to train artificial intelligence models, or allow its providers to do so. If WeWomen wished to use anonymised data for research purposes, it would ask the Participant for specific, separate and optional consent, and refusing would not affect her participation in the Beta Version.
12. Intellectual and industrial property
The platform, its code, its design, the WeWomen brand and the editorial content belong to WeWomen or its licensors. Signed articles belong to their authors. These terms grant the Participant no rights other than personal use of the Beta Version.
13. Data protection
WeWomen processes the Participant's personal data in accordance with Regulation (EU) 2016/679 (GDPR) and Spanish Organic Law 3/2018. This clause contains all the data protection information applicable to the Beta Version.
| Heading | Information |
|---|---|
| Controller | BAUBER.XYZ, S.L., tax ID (NIF) B93944700, with address at Rambla del Poblenou, 38, 08005 Barcelona, Spain. Contact: hola@wewomen.health. |
| Purposes | Managing participation in the Beta Version and providing the service. Processing the health information the Participant provides in order to answer her questions and build her history. Analysing questionnaires and feedback to improve the product. Questionnaires are processed with a code, without the Participant's name or email. The code comes in the link and allows the initial and final questionnaires to be matched. If the Participant transcribes a consultation, the transcript also contains data about the healthcare professional, which WeWomen processes solely to store the transcript in the Participant's history, on the basis of its legitimate interest and with the permission the Participant must ask for before transcribing (clause 7). |
| Legal basis | Performance of these terms (Art. 6.1.b GDPR). Explicit consent for health data (Art. 9.2.a GDPR) and for the questionnaires (Art. 6.1.a GDPR), which may be withdrawn at any time. Consent for health data is collected through a specific checkbox, separate from the acceptance of these terms. The Participant may withdraw her consents at any time from the Consents section of the app or by writing to hola@wewomen.health. Withdrawal does not affect the lawfulness of prior processing. If she withdraws consent for health data, WeWomen will no longer be able to provide the service and will delete that data within the period set out under Retention. |
| Recipients | Providers that process data on WeWomen's behalf (hosting, language models and communications), under a data processing agreement. No data is disclosed to third parties except where required by law or in the transfer described in clause 1 (Art. 21 LOPDGDD). WeWomen does not sell data or disclose it to employers, insurers or advertisers. |
| Transfers | Data may be processed by providers located in the European Economic Area or, where applicable, through mechanisms recognised by data protection law. |
| Retention | For as long as the Participant keeps her account. If she requests deletion, or if the Beta Version ends without a public version, the data will be deleted within 30 days at most, except data that must be kept by law, which will be blocked for the legal period. |
| Rights | Access, rectification, erasure, objection, restriction and portability, by writing to hola@wewomen.health. Complaints may be lodged with the Spanish Data Protection Agency (aepd.es). |
When a company offers WeWomen to its employees, it will never receive any individual data about the Participant. WeWomen will only provide data to the authorities in response to a valid legal request, will review each request and will inform the Participant unless the law prevents it.
14. Duration and termination
The trial period lasts three weeks from activation of access. Afterwards, the Participant may continue to use the Beta Version until 19 February 2027. The Participant may leave the Beta Version at any time, without giving a reason, export her information and request the deletion of her account and data. WeWomen may end the Beta Version, or the participation of anyone who seriously breaches these terms, with prior notice unless the law prevents it.
When the Beta Version ends, the account and the stored information are kept so that the Participant can continue to use them in the public version of WeWomen, unless she requests their deletion.
If WeWomen does not launch a public version, it will inform the Participant and delete her data within the period set out in clause 13.
15. Liability
WeWomen is not liable for health decisions the Participant makes on the basis of information from the Beta Version without consulting a healthcare professional, for damage arising from use contrary to these terms or from the operation of third-party devices and services, or for temporary unavailability, malfunctions or loss of information caused by third-party technology providers. Nothing above limits liability that cannot be limited by law, in particular liability for wilful misconduct or gross negligence, or the rights that consumer protection law grants the Participant.
16. Changes
WeWomen may amend these terms while the Beta Version is available and will notify relevant changes by email before they apply. If the Participant does not agree, she may leave the Beta Version at any time.
17. Governing law and jurisdiction
These terms are governed by Spanish law, without prejudice to the mandatory consumer protection rules of the Participant's country of residence. Any dispute shall be heard by the courts of the Participant's place of residence.
18. Contact
For any question, issue or complaint, the Participant may write to hola@wewomen.health.